Global Active Hemostatic Agents Market: Industry Analysis & Forecast 2020-2026, By Products, End User and Region.

Global Active Hemostatic Agents Market size was valued at USD xx billion in 2019 and is expected to reach US$ 5.44 billion by 2026, at a CAGR of xx% during a forecast period.

Global Active Hemostatic Agents Market Definition

Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research. The report covers the current estimated and forecasted data for the Global Active Hemostatic Agents Market on a global and regional level. The report provides an in-depth analysis of the Global Active Hemostatic Agents Market for the period 2019 – 2026, wherein 2019 is the base year and the period from 2020 to 2026 is the forecast period. The Global Active Hemostatic Agents Market is segmented by Product, End-Use and Region. The report provides qualitative and quantitative insights on the Active Hemostatic Agents Market industry trends and a detailed analysis of the market size and growth rate of all segments in the market.

Global Active Hemostatic Agents Market Dynamics

Hemorrhage occurring during and after surgery still remains one of the biggest problems in medicine. Uncontrolled hemorrhage remains one of the most significant causes of mortality in patients with traumas of various etiologies and medical conditions. There are a variety of methods available to reduce bleeding time & amount of blood loss. Hence, the use of active hemostatic agent’s remains the most popular and common way due to its simplicity, efficiency and ease of application. Mechanical and active topical sealant and hemostatic agents are now widely available in several different forms. Applications of active hemostatic agents in the improvement of one of the most difficult cardiovascular procedures and repair of acute aortic dissection are the major factor driving the global market. Continuously ongoing research & development activities on the potential of new hemostatic agents led to give the lucrative opportunity for the global market. Improvements in the efficacy of these hemostatic agents, as well as delivery systems and product safety, will make these agents even better and more widely accepted.

Global Active Hemostatic Agents Market Segment Analysis

Global Active Hemostatic Agents Market To know about the Research Methodology :- Request Free Sample Report

Thrombin based hemostat product is widely used by surgeons during various surgical procedures.

Recently a recombinant thrombin based hemostat has been developed and approved for use by the Food Drug Administration. It has the advantage of being minimally antigenic and devoid of the risk of viral transmission. Thrombin based hemostat has grown exponentially, and now thrombin is used in more than 1 million patients in the United States each year at a cost of US$250 million. Recently there have been new developments in thrombin and FDA approvals in human thrombin commended the largest share XX% of the segment. The growing roles of thrombin based hemostat in hemostasis, inflammation and cell signalling are driving the global market.

The hospital segment commanded the largest market share of XX% in the global market.

Effective management in operating procedures for positive outcomes in the surgeries is boosting the global market. Continuing education activity to educate perioperative registered nurses (RNs) about the effective management of hemostasis in the surgical patient. Various methods available for control of bleeding during surgery are driving the global market.

Global Active Hemostatic Agents Market Regional Analysis

Global Active Hemostatic Agents Market 1

North America dominates the global active hemostatic agents market and it is expected to maintain its position in the forecast period.

The high prevalence of cardiovascular disease and higher adoption of active hemostatic agents are anticipated to show growth in this region. Development in the public healthcare environment and the increasing prevalence of surgical procedures are showing growth for the global market. The objective of the report is to present a comprehensive analysis of the global active hemostatic agents market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. Surgical sealants as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global active hemostatic agents market dynamics, structure by analyzing the market segments and projects the global active hemostatic agents market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global active hemostatic agents market make the report investor’s guide.

Global Active Hemostatic Agents Market Report Scope: Inquire before buying

Global Active Hemostatic Agents Market 2

Global Active Hemostatic Agents Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global Active Hemostatic Agents Market Key Players

• Medtronic Plc. • Ethicon Inc. • Pfizer Inc. • Baxter International Inc. • CryoLife Inc. • Integra Life Sciences Corporation, etc. • Stryker • Cryolife Inc • Biom’up • BD • Johnson & Johnson Services • C.R.Bard • B. Braun Melsungen AG • Z-Medica LLC • Advanced Medical Solutions Group plc • GELITA GA • Active Hemostatic Agents • Warrior Tactical, LLC
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Active Hemostatic Agents Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Active Hemostatic Agents Market 3.4. Geographical Snapshot of the Active Hemostatic Agents Market, By Manufacturer share 4. Global Active Hemostatic Agents Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Active Hemostatic Agents Market 5. Supply Side and Demand Side Indicators 6. Global Active Hemostatic Agents Market Analysis and Forecast, 2019-2026 6.1. Global Active Hemostatic Agents Market Size & Y-o-Y Growth Analysis. 7. Global Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 7.1.1. Thrombin based hemostats 7.1.2. Surgical sealants 7.1.3. Combination Products 7.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 7.2.1. Hospitals 7.2.2. Ambulatory Surgical Centers 7.2.3. Specialty Clinics 8. Global Active Hemostatic Agents Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 9.1.1. Thrombin based hemostats 9.1.2. Surgical sealants 9.1.3. Combination Products 9.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 9.2.1. Hospitals 9.2.2. Ambulatory Surgical Centers 9.2.3. Specialty Clinics 10. North America Active Hemostatic Agents Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 12. Canada Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 13. Mexico Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 14. Europe Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 15. Europe Active Hemostatic Agents Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 17. France Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 18. Germany Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 19. Italy Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 20. Spain Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 21. Sweden Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 22. CIS Countries Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 23. Rest of Europe Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 24. Asia Pacific Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 25. Asia Pacific Active Hemostatic Agents Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 27. India Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 28. Japan Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 29. South Korea Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 30. Australia Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 31. ASEAN Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 32. Rest of Asia Pacific Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 33. Middle East Africa Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 34. Middle East Africa Active Hemostatic Agents Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 36. GCC Countries Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 37. Egypt Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 38. Nigeria Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 39. Rest of ME&A Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 40. South America Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 41. South America Active Hemostatic Agents Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 43. Argentina Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 44. Rest of South America Active Hemostatic Agents Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Active Hemostatic Agents Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Medtronic Plc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Ethicon Inc. 45.3.3. Pfizer Inc. 45.3.4. Baxter International Inc. 45.3.5. CryoLife Inc. 45.3.6. Integra Life Sciences Corporation, etc. 45.3.7. Stryker 45.3.8. Cryolife Inc 45.3.9. Biom’up 45.3.10. BD 45.3.11. Johnson & Johnson Services 45.3.12. C.R.Bard 45.3.13. B. Braun Melsungen AG 45.3.14. Z-Medica LLC 45.3.15. Advanced Medical Solutions Group plc 45.3.16. GELITA GA 45.3.17. Active Hemostatic Agents 45.3.18. Warrior Tactical, LLC 46. Primary Key Insights

About This Report

Report ID 97666
Category Healthcare
Published Date April 2021
Updated Date
Contact Us